New rapid test could help ICU doctors pick the right antibiotic faster

NCT ID NCT03711331

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a rapid test called Unyvero could help doctors choose the right antibiotic sooner for patients with pneumonia who are on breathing machines in the ICU. The test looks for bacteria and their resistance genes in just a few hours, compared to standard lab cultures that take days. Researchers compared patients whose treatment was guided by the rapid test to those receiving standard care, to see if more patients got targeted antibiotics within 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Unyvero multiplex PCR test (diagnostic test)

What this could lead to

If successful, this rapid test could help doctors choose the right antibiotic sooner for pneumonia patients on ventilators, reducing unnecessary broad-spectrum antibiotic use.

What could go wrong

This is a completed study with 161 patients, but the test may not always match traditional culture results, and faster treatment may not always improve outcomes. Results need confirmation in larger studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial pneumonia Healthcare-Associated Pneumonia nosocomial infection Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Lille

    Lille, France